Days to Event317 days
VenueHotel Village Changi, Singapore
Abstract DeadlineFebruary 20, 2027
Early Bird EndsJuly 14, 2026
Register Now

Spasticity Management

19
Session · 19 of 35

Spasticity Management

Spasticity treatment spans medication, injection and surgery with multiple botulinum toxin formulations. The session covers botulinum toxin protocols (onabotA Botox, abobotA Dysport, incobotA Xeomin, prabotA Daxxify), oral antispasticity agents (baclofen, tizanidine, dantrolene), intrathecal baclofen pumps (Medtronic Synchromed II), phenol nerve blocks, selective dorsal rhizotomy in cerebral palsy, and emerging selective denervation procedures. Discussion addresses spasticity by aetiology (stroke vs SCI vs CP vs MS), botulinum toxin formulation comparison, post-injection rehabilitation, physical therapy in spasticity, pediatric spasticity, and nabiximols in MS-related spasticity.

Topics covered in this session
  • Botulinum toxin formulations
  • Baclofen/tizanidine/dantrolene
  • Intrathecal baclofen pumps
  • Phenol nerve blocks
  • Selective dorsal rhizotomy
  • Spasticity by aetiology
  • Pediatric spasticity
  • Nabiximols MS spasticity